Data for: A 73-gene Proliferative Transcriptomic Signature Predicts Uterine Serous Carcinoma Patient Survival and Response to Primary Therapy

Published: 7 May 2020| Version 1 | DOI: 10.17632/kjmmvtdssg.1
Contributors:
Jin-Xiong She,

Description

De-identified uterine serous carcinoma patients' gene expression information and clinicodemographic information.

Files

Categories

Transcriptomics, Gynecologic Pathology, Biomarker Validation

License